Subjects - Finance

Let’s start this week by looking at the end of last week. We mentioned that we are extremely cautious of Fridays. We

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

generally don’t trade, or trade less, on Fridays.

For some reason, we have not had much luck with trading on Fridays

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

Levels that hold as support or resistance all week long crumble like dust in the wind on Fridays.

So, that being sa

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

d, it happened again. We had used 1.8760 as support a few times last week, but had no faith in it for Friday’s tradin

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

g. Fortunately for us, we stayed true to our guns and stayed out of the market.

As you saw, 1.8760 was broken like a

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

wet tissue. We didn’t see any good reason for this, but reasons seem to matter less on Friday’s than all other days o

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

the week. Maybe it’s the mad dash of traders trying to make those extra few bucks before the weekend or close out th

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

eir positions. Who knows?

Ok, last note about Friday. There were several key support levels / indicators that we wat

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

h which were broken on Friday. That gives us good reason to look for a short today.

So, now on to today’s trading.

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

lthough some of our traders disagree with us, we are going to look only to play the short side of Cable today.

Our a

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

gressive traders argue that 1.8700 is a good support level, and have taken long positions from there with hopes of a

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

climb. Hey, to each their own.

We, on the other hand, are looking at resistance levels in the high 1.8700’s all the

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ay up to 1.8800. There are more resistance levels at 1.8820, 1.8850, and then as high as 1.8890 – 1.8900.

It’s actu

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

lly pretty slim pickings when it comes to finding a good stop price, so be careful.

This is another great time to me

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ntion that No Trade Is Better Than A Bad Trade. A bad trade is one when you don’t have all the important information

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

Make sure that you have all the levels necessary for a good trade – the entry, the stop, and the profit target.

We

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ind these support and resistance levels using a set of technical indicators and other variables that we have found to

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

be most successful for us. We use several other indicators and a variety of technical analysis techniques to enter a

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

d exit all of our trades. Every trader will have a different combination of indicators that makes the most sense to t

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

em. Learn how to develop your own successful Forex Trading style with our Elite Forex Trading Course or Forex Seminar

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.subjects.org.ua/article/95574/subjects-Trading-In-Black-And-White-Forex-Trading-Newsletter--52206.html">Trading In Black And White Forex Trading Newsletter – 5/22/06</a>

BB link (for phorums):
[url=http://www.subjects.org.ua/article/95574/subjects-Trading-In-Black-And-White-Forex-Trading-Newsletter--52206.html]Trading In Black And White Forex Trading Newsletter – 5/22/06[/url]

If you are a loan officer or mortgage broker that is in the market for mortgage leads, your salesmanship has a lot to do with the end results of the mortgage leads you receive.

Knowing how to read a Material Safety Data Sheet (MSDS) is one way to make sure that your cleaning staff has all of the information they need to know about the hazards and safe handling of chemicals used on the job. Don't just give your staff MSDS sheets; train your staff how to read and understand the material contained within the MSDS.

The best tools to use for keyword research is paid for tools, the free tools just don't have the features.

Tags

Links

Subjects - Trading In Black And White Forex Trading Newsletter – 5/22/06

Related Articles: